News & Media
Commercial Product Activities and Platform Validation
LIVIUS’s science-driven commercial products continue to serve as real-world validation of our technology platform. Insights generated through these applications inform ongoing research and...
Advancement of Cellular Reprogramming Platform
LIVIUS continues to advance its cellular reprogramming platform based on miRNA biology, small-molecule epigenetic control, and DNA repair mechanisms. Current efforts are focused on strengthening...
Beginning of Ongoing Company Communications
LIVIUS is beginning a structured approach to external communications, sharing selected updates on our technology platform, research activities, and business progress. Information will be released...